ONYX-015: mechanisms of action and clinical potential of a replication-selective adenovirus

por Ries, S, Korn, W M
Publicado 2002

RNA interference-mediated knockdown of p21(WAF1) enhances anti-tumor cell activity of oncolytic adenoviruses

por Shiina, M, Lacher, M D, Christian, C, Korn, W M
Publicado 2009

Minimal hepatic toxicity of Onyx-015: spatial restriction of coxsackie-adenoviral receptor in normal liver

por Au, T, Thorne, S, Korn, W M, Sze, D, Kirn, D, Reid, T R
Publicado 2006

A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer

por Kelley, R K, Hwang, J, Magbanua, M J M, Watt, L, Beumer, J H, Christner, S M, Baruchel, S, Wu, B, Fong, L, Yeh, B M, Moore, A P, Ko, A H, Korn, W M, Rajpal, S, Park, J W, Tempero, M A, Venook, A P, Bergsland, E K
Publicado 2013